Home > Research > Publications & Outputs > Apolipoprotein L1 Variant Associated with Incre...

Links

Text available via DOI:

View graph of relations

Apolipoprotein L1 Variant Associated with Increased Susceptibility to Trypanosome Infection

Research output: Contribution to Journal/MagazineJournal articlepeer-review

Published

Standard

Apolipoprotein L1 Variant Associated with Increased Susceptibility to Trypanosome Infection. / Cuypers, Bart; Lecordier, Laurence; Meehan, Conor J. et al.
In: MBio, Vol. 7, No. 2, e02198-15, 04.05.2016.

Research output: Contribution to Journal/MagazineJournal articlepeer-review

Harvard

Cuypers, B, Lecordier, L, Meehan, CJ, Van den Broeck, F, Imamura, H, Buscher, P, Dujardin, J-C, Laukens, K, Schnaufer, A, Dewar, C, Lewis, M, Balmer, O, Azurago, T, Kyei-Faried, S, Ohene, S-A, Duah, B, Homiah, P, Mensah, EK, Anleah, F, Franco, JR, Pays, E & Deborggraeve, S 2016, 'Apolipoprotein L1 Variant Associated with Increased Susceptibility to Trypanosome Infection', MBio, vol. 7, no. 2, e02198-15. https://doi.org/10.1128/MBIO.02198-15

APA

Cuypers, B., Lecordier, L., Meehan, C. J., Van den Broeck, F., Imamura, H., Buscher, P., Dujardin, J.-C., Laukens, K., Schnaufer, A., Dewar, C., Lewis, M., Balmer, O., Azurago, T., Kyei-Faried, S., Ohene, S.-A., Duah, B., Homiah, P., Mensah, E. K., Anleah, F., ... Deborggraeve, S. (2016). Apolipoprotein L1 Variant Associated with Increased Susceptibility to Trypanosome Infection. MBio, 7(2), Article e02198-15. https://doi.org/10.1128/MBIO.02198-15

Vancouver

Cuypers B, Lecordier L, Meehan CJ, Van den Broeck F, Imamura H, Buscher P et al. Apolipoprotein L1 Variant Associated with Increased Susceptibility to Trypanosome Infection. MBio. 2016 May 4;7(2):e02198-15. Epub 2016 Apr 12. doi: 10.1128/MBIO.02198-15

Author

Cuypers, Bart ; Lecordier, Laurence ; Meehan, Conor J. et al. / Apolipoprotein L1 Variant Associated with Increased Susceptibility to Trypanosome Infection. In: MBio. 2016 ; Vol. 7, No. 2.

Bibtex

@article{240854ee7c8b4c5d8e055be73bf694fb,
title = "Apolipoprotein L1 Variant Associated with Increased Susceptibility to Trypanosome Infection",
abstract = "African trypanosomes, except Trypanosoma brucei gambiense and Trypanosoma brucei rhodesiense, which cause human African trypanosomiasis, are lysed by the human serum protein apolipoprotein L1 (ApoL1). These two subspecies can resist human ApoL1 because they express the serum resistance proteins T. b. gambiense glycoprotein (TgsGP) and serum resistance-associated protein (SRA), respectively. Whereas in T. b. rhodesiense, SRA is necessary and sufficient to inhibit ApoL1, in T. b. gambiense, TgsGP cannot protect against high ApoL1 uptake, so different additional mechanisms contribute to limit this uptake. Here we report a complex interplay between trypanosomes and an ApoL1 variant, revealing important insights into innate human immunity against these parasites. Using whole-genome sequencing, we characterized an atypical T. b. gambiense infection in a patient in Ghana. We show that the infecting trypanosome has diverged from the classical T. b. gambiense strains and lacks the TgsGP defense mechanism against human serum. By sequencing the ApoL1 gene of the patient and subsequent in vitro mutagenesis experiments, we demonstrate that a homozygous missense substitution (N264K) in the membrane-addressing domain of this ApoL1 variant knocks down the trypanolytic activity, allowing the trypanosome to avoid ApoL1-mediated immunity.IMPORTANCE Most African trypanosomes are lysed by the ApoL1 protein in human serum. Only the subspecies Trypanosoma b. gambiense and T. b. rhodesiense can resist lysis by ApoL1 because they express specific serum resistance proteins. We here report a complex interplay between trypanosomes and an ApoL1 variant characterized by a homozygous missense substitution (N264K) in the domain that we hypothesize interacts with the endolysosomal membranes of trypanosomes. The N264K substitution knocks down the lytic activity of ApoL1 against T. b. gambiense strains lacking the TgsGP defense mechanism and against T. b. rhodesiense if N264K is accompanied by additional substitutions in the SRA-interacting domain. Our data suggest that populations with high frequencies of the homozygous N264K ApoL1 variant may be at increased risk of contracting human African trypanosomiasis.",
author = "Bart Cuypers and Laurence Lecordier and Meehan, {Conor J.} and {Van den Broeck}, Frederik and Hideo Imamura and Philippe Buscher and Jean-Claude Dujardin and Kris Laukens and Achim Schnaufer and Caroline Dewar and Michael Lewis and Oliver Balmer and Thomas Azurago and Sardick Kyei-Faried and Sally-Ann Ohene and Boateng Duah and Prince Homiah and Mensah, {Ebenezer Kofi} and Francis Anleah and Franco, {Jose Ramon} and Etienne Pays and Stijn Deborggraeve",
year = "2016",
month = may,
day = "4",
doi = "10.1128/MBIO.02198-15",
language = "English",
volume = "7",
journal = "MBio",
issn = "2161-2129",
publisher = "American Society for Microbiology",
number = "2",

}

RIS

TY - JOUR

T1 - Apolipoprotein L1 Variant Associated with Increased Susceptibility to Trypanosome Infection

AU - Cuypers, Bart

AU - Lecordier, Laurence

AU - Meehan, Conor J.

AU - Van den Broeck, Frederik

AU - Imamura, Hideo

AU - Buscher, Philippe

AU - Dujardin, Jean-Claude

AU - Laukens, Kris

AU - Schnaufer, Achim

AU - Dewar, Caroline

AU - Lewis, Michael

AU - Balmer, Oliver

AU - Azurago, Thomas

AU - Kyei-Faried, Sardick

AU - Ohene, Sally-Ann

AU - Duah, Boateng

AU - Homiah, Prince

AU - Mensah, Ebenezer Kofi

AU - Anleah, Francis

AU - Franco, Jose Ramon

AU - Pays, Etienne

AU - Deborggraeve, Stijn

PY - 2016/5/4

Y1 - 2016/5/4

N2 - African trypanosomes, except Trypanosoma brucei gambiense and Trypanosoma brucei rhodesiense, which cause human African trypanosomiasis, are lysed by the human serum protein apolipoprotein L1 (ApoL1). These two subspecies can resist human ApoL1 because they express the serum resistance proteins T. b. gambiense glycoprotein (TgsGP) and serum resistance-associated protein (SRA), respectively. Whereas in T. b. rhodesiense, SRA is necessary and sufficient to inhibit ApoL1, in T. b. gambiense, TgsGP cannot protect against high ApoL1 uptake, so different additional mechanisms contribute to limit this uptake. Here we report a complex interplay between trypanosomes and an ApoL1 variant, revealing important insights into innate human immunity against these parasites. Using whole-genome sequencing, we characterized an atypical T. b. gambiense infection in a patient in Ghana. We show that the infecting trypanosome has diverged from the classical T. b. gambiense strains and lacks the TgsGP defense mechanism against human serum. By sequencing the ApoL1 gene of the patient and subsequent in vitro mutagenesis experiments, we demonstrate that a homozygous missense substitution (N264K) in the membrane-addressing domain of this ApoL1 variant knocks down the trypanolytic activity, allowing the trypanosome to avoid ApoL1-mediated immunity.IMPORTANCE Most African trypanosomes are lysed by the ApoL1 protein in human serum. Only the subspecies Trypanosoma b. gambiense and T. b. rhodesiense can resist lysis by ApoL1 because they express specific serum resistance proteins. We here report a complex interplay between trypanosomes and an ApoL1 variant characterized by a homozygous missense substitution (N264K) in the domain that we hypothesize interacts with the endolysosomal membranes of trypanosomes. The N264K substitution knocks down the lytic activity of ApoL1 against T. b. gambiense strains lacking the TgsGP defense mechanism and against T. b. rhodesiense if N264K is accompanied by additional substitutions in the SRA-interacting domain. Our data suggest that populations with high frequencies of the homozygous N264K ApoL1 variant may be at increased risk of contracting human African trypanosomiasis.

AB - African trypanosomes, except Trypanosoma brucei gambiense and Trypanosoma brucei rhodesiense, which cause human African trypanosomiasis, are lysed by the human serum protein apolipoprotein L1 (ApoL1). These two subspecies can resist human ApoL1 because they express the serum resistance proteins T. b. gambiense glycoprotein (TgsGP) and serum resistance-associated protein (SRA), respectively. Whereas in T. b. rhodesiense, SRA is necessary and sufficient to inhibit ApoL1, in T. b. gambiense, TgsGP cannot protect against high ApoL1 uptake, so different additional mechanisms contribute to limit this uptake. Here we report a complex interplay between trypanosomes and an ApoL1 variant, revealing important insights into innate human immunity against these parasites. Using whole-genome sequencing, we characterized an atypical T. b. gambiense infection in a patient in Ghana. We show that the infecting trypanosome has diverged from the classical T. b. gambiense strains and lacks the TgsGP defense mechanism against human serum. By sequencing the ApoL1 gene of the patient and subsequent in vitro mutagenesis experiments, we demonstrate that a homozygous missense substitution (N264K) in the membrane-addressing domain of this ApoL1 variant knocks down the trypanolytic activity, allowing the trypanosome to avoid ApoL1-mediated immunity.IMPORTANCE Most African trypanosomes are lysed by the ApoL1 protein in human serum. Only the subspecies Trypanosoma b. gambiense and T. b. rhodesiense can resist lysis by ApoL1 because they express specific serum resistance proteins. We here report a complex interplay between trypanosomes and an ApoL1 variant characterized by a homozygous missense substitution (N264K) in the domain that we hypothesize interacts with the endolysosomal membranes of trypanosomes. The N264K substitution knocks down the lytic activity of ApoL1 against T. b. gambiense strains lacking the TgsGP defense mechanism and against T. b. rhodesiense if N264K is accompanied by additional substitutions in the SRA-interacting domain. Our data suggest that populations with high frequencies of the homozygous N264K ApoL1 variant may be at increased risk of contracting human African trypanosomiasis.

UR - https://publons.com/wos-op/publon/5064368/

U2 - 10.1128/MBIO.02198-15

DO - 10.1128/MBIO.02198-15

M3 - Journal article

VL - 7

JO - MBio

JF - MBio

SN - 2161-2129

IS - 2

M1 - e02198-15

ER -